Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ INTRODUCTION ++ Pharmacology. Sodium nitrite injectable solution and amyl nitrite crushable ampules for inhalation are components of the cyanide antidote package. The value of nitrites as an antidote to cyanide poisoning is twofold: They oxidize hemoglobin to methemoglobin, which binds free cyanide, and they may enhance endothelial cyanide detoxification by producing vasodilation. Inhalation of an ampule of amyl nitrite produces a methemoglobin level of about 5%. Intravenous administration of a single 300-mg dose of sodium nitrite in adults is anticipated to produce a methemoglobin level of about 15-20%. Indications Symptomatic cyanide poisoning. Nitrites are not usually used for empiric treatment unless cyanide is suspected very strongly, and they are not recommended for smoke inhalation victims. Nitrites are possibly effective for hydrogen sulfide poisoning if given within 30 minutes of exposure. Contraindications Significant preexisting methemoglobinemia (>40%). Severe hypotension is a relative contraindication because it may be worsened by nitrites. Administration to patients with concurrent carbon monoxide poisoning is a relative contraindication; generation of methemoglobin may further compromise oxygen transport to the tissues. Hydroxocobalamin has supplanted nitrites for smoke inhalation victims (patients often have mixed carbon monoxide and cyanide poisoning) in countries where it is available. Adverse effects Headache, facial flushing, dizziness, nausea, vomiting, tachycardia, and sweating may occur. These side effects may be masked by the symptoms of cyanide poisoning. Rapid intravenous administration may result in hypotension. Excessive and potentially fatal methemoglobinemia may result. Use in pregnancy. No assigned FDA category. These agents may compromise blood flow and oxygen delivery to the fetus and may induce fetal methemoglobinemia. Fetal hemoglobin is more sensitive to the oxidant effects of nitrites. However, this does not preclude their acute, short-term use for a seriously symptomatic patient (Introduction). Drug or laboratory interactions Hypotension may be exacerbated by the concurrent presence of alcohol or other vasodilators or any antihypertensive agent. Methylene blue should not be administered to a cyanide-poisoned patient because it may reverse nitrite-induced methemoglobinemia and theoretically result in the release of free cyanide ions. However, it may be considered when severe and life-threatening excessive methemoglobinemia is present. Binding of methemoglobin to cyanide (cyanomethemoglobin) may lower the measured free methemoglobin level. Dosage and method of administration Amyl nitrite crushable ampules. Crush one to two ampules in gauze, cloth, or a sponge and place under the nose of the victim, who should inhale deeply for 30 seconds. Rest for 30 seconds, then repeat. Each ampule lasts about 2–3 minutes. If the victim is receiving respiratory support, place the ampules in the face mask or port access to the endotracheal tube. Stop ampule use when administering intravenous sodium nitrite. Sodium nitrite parenteral Adults. Administer 300 mg of sodium nitrite (10 mL of 3% solution) IV over 3–5 minutes. Children. Give 5.8-11.6 mg/kg to a maximum of 300 mg. Pediatric dosing should be based on the hemoglobin concentration if it is known (Table III–13). If anemia is suspected or hypotension is present, start with the lower ... Your Access profile is currently affiliated with '[InstitutionA]' and is in the process of switching affiliations to '[InstitutionB]'. Please click ‘Continue’ to continue the affiliation switch, otherwise click ‘Cancel’ to cancel signing in. Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Username Error: Please enter User Name Password Error: Please enter Password Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free a profile for additional features.